Abiopharma

News list

Hoppenot Herve 🟢 acquired 9.1K shares (1 derivative) of BICYCLE THERAPEUTICS PLC (BCYC) at $7.08 Transaction Date: Jan 02, 2026 | Filing ID: 000002

Full text

News bot Jan. 7, 2026, 1:19 a.m.
🔍 Hoppenot Herve (Executive)

Company: BICYCLE THERAPEUTICS PLC (BCYC)

Report Date: 2026-01-02
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 9,097
Detailed Transactions and Holdings:
- Acquired 3,032 shares of Ordinary Shares (Direct)
  Date: 2026-01-02 | Code: A | equity_swap_involved: 0 | shares_owned_after: 15,532.00 | transaction_form_type: 4 | Footnotes: F1, F2
- Acquired 6,065 shares of Stock Option (right to buy) at $7.08 per share (Derivative)
  Date: 2026-01-02 | Code: A | Expires: 2036-01-02 | equity_swap_involved: 0 | shares_owned_after: 6,065.00 | transaction_form_type: 4 | Footnotes: F3
Footnotes:
- F1: Represents a restricted share unit ("RSU") award. The RSUs shall vest in four equal installments on March 15, 2026, June 15, 2026, September 15, 2026 and December 15, 2026.
- F2: Each RSU represents a contingent right to receive one ordinary share.
- F3: This option shall vest in four equal installments on March 15, 2026, June 15, 2026, September 15, 2026 and December 15, 2026.